SCHEMBL8501233

SCHEMBL8501233

CCCCN(CC(F)(F)F)C(=O)C1c2ccccc2-c2cccc(N3CC(NC(=O)c4ccccc4)C3)c21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPSR1 Q6W5P4 1/20 0.36
▸ UTS2R Q9UKP6 1/20 0.34
▸ HDAC1 Q13547 2/20 0.34
▸ HDAC6 Q9UBN7 2/20 0.34
▸ HPGD P15428 1/20 0.33
▸ KCNH2 Q12809 1/20 0.33
▸ SCN9A Q15858 1/20 0.33
▸ CHRM1 P11229 1/20 0.33
▸ HDAC3 O15379 1/20 0.33
▸ HDAC2 Q92769 1/20 0.33
▸ HTR2A P28223 1/20 0.32
▸ DRD2 P14416 2/20 0.32
▸ DRD3 P35462 1/20 0.32
▸ DRD4 P21917 1/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ TSHR P16473 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32
▸ CCKAR P32238 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8501048 0.98 NPSR1 (0.35) NPSR1UTS2RHPGDKCNH2SCN9A
SCHEMBL8665880 0.94 UTS2R (0.39) NPSR1UTS2RCHRM1DRD2DRD4
SCHEMBL8485533 0.92 NPSR1 (0.42) NPSR1UTS2RSCN9AHTR2ADRD2
SCHEMBL8666092 0.91 UTS2R (0.39) NPSR1UTS2RCHRM1DRD2DRD4
SCHEMBL8502237 0.91 NPSR1 (0.38) NPSR1UTS2RHDAC1HDAC6HPGD
SCHEMBL8484454 0.90 NPSR1 (0.42) NPSR1UTS2RSCN9AHTR2ADRD2
SCHEMBL8500996 0.89 CTSL (0.37) HDAC1HDAC6HDAC3HDAC2HTR2A
SCHEMBL8504375 0.88 CCR3 (0.38) NPSR1UTS2RDRD2DRD4CYP1A2
SCHEMBL8669685 0.84 NPSR1 (0.42) NPSR1UTS2RCHRM1DRD2DRD4
SCHEMBL8665488 0.83 CCR2 (0.37) KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5885983-A ANTICHOLESTEROL AGENTS, ANTILIPOLYTIC AGENTS, ANTILIPEMIC AGENTS FOR TREATING HYPERLIPEMIA, ATHEROSCLEROSIS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-03-23 — — US claimed
US-5885983-A ANTICHOLESTEROL AGENTS, ANTILIPOLYTIC AGENTS, ANTILIPEMIC AGENTS FOR TREATING HYPERLIPEMIA, ATHEROSCLEROSIS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-03-23 — — US disclosed
Send feedback